support thyroid research
Clinical Thyroidology for Patients

Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association.
Editor-in-chief, Alan Farwell, MD

April Thyroid Awareness

Volume 8 Issue 8

Available in pdf format for saving and printing and Web page format for viewing online

PDF Format for Saving and Printing

Clinical Thyroidology for the Public Volume 8 Issue 8 (PDF file, 767 KB)


Editor’s Comments

HYPOTHYROIDISM The presence of hypothyroid symptoms is more reliable in diagnosing hypothyroidism in men than in women
Carlé A et al. Gender differences in symptoms of hypothyroidism: a population-based DanThyr study. Clin Endocrinol (Oxf). April 2, 2015 [Epub ahead of print]..
(PDF File for saving and printing, 136 KB)

THYROID CANCER Increasing trend of thyroid cancer
Brito JP et al. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid (ePub)
(PDF File for saving and printing, 69 KB)

HYPERTHYROIDISM Could pretreatment with MMI be as effective as rhTSH in treating subclinical toxic multinodular goiter with 131I?
Kyrilli A et al Thiamazole pretreatment lowers the 131I activity needed to cure hyperthyroidism in patients with nodular goiter. J Clin Endocrinol Metab. April 13, 2015 [E-pub ahead of print].
(PDF File for saving and printing, 76 KB)

HYPERTHYROIDISM Radioactive iodine increases the risk of strokes in patients with hyperthyroidism or nodular goiter
la Cour JL et al. Radioiodine therapy increases the risk of cerebrovascular events in hyperthyroid and euthyroid patients. Eur J Endocrinol 2015; 172:771-8.
(PDF File for saving and printing, 119 KB)

THYROID CANCER Radioactive iodine treatment improves survival in adults with intermediate risk papillary thyroid cancer
Ruel E. Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients with Intermediate-Risk Papillary Thyroid Cancer. J Clin Endocrine Metab April, 2015;100:1529-36
(PDF File for saving and printing, 73 KB)